NCT05238922 2026-04-14Study of INCB123667 in Subjects With Advanced Solid TumorsIncyte CorporationPhase 1 Recruiting604 enrolled
NCT03294694 2025-05-31Ribociclib + PDR001 in Breast Cancer and Ovarian CancerDana-Farber Cancer InstitutePhase 1 Terminated33 enrolled
NCT04726332 2024-05-14Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101)ExelixisPhase 1 Terminated52 enrolled